Digitisation | May 01, 2023
Aptar Digital Health and Healint collaborate for Central Nervous System
The partnership will capitalize on the combined capabilities of the two organizations
The partnership will capitalize on the combined capabilities of the two organizations
The trials -- ELOWEN-1 and ELOWEN-2 -- are designed to evaluate the drug in people living with lupus who experience active skin manifestations
The company announced that its Phase III FENhance 1 and 2 studies both met their primary endpoints
The drug is designed to provide temporary relief from cough caused by throat and bronchial irritation
Integrated eCOA technology and rater training aim to reduce variability and strengthen ClinRO outcomes
Acquires 85% stake in the formulations company valued at Rs 200 crore enterprise value; founder Vivek Seth to retain 15%
Sugammadex injection is bioequivalent to Merck’s Bridion injection for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide in adults and pediatric patients aged 2 years and older undergoing surgery
Call it a major breakthrough for diagnostic imaging
Rivotril is the innovator/ reference brand of clonazepam and is widely prescribed for the management of neurological and psychiatric conditions
The NeuroSakhi initiative aims to close these gaps by strengthening awareness, building patient support networks and improving engagement between healthcare professionals, patients and caregivers across Punjab
Subscribe To Our Newsletter & Stay Updated
